This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Innovaro, Inc. Reports Financial Results For The Three Months Ended June 30, 2012

Innovaro, Inc. (NYSE Amex: INV), today announced that total revenue from continuing operations was $1.9 million for the quarter ended June 30, 2012 as compared to $800,000 for the quarter ended March 31, 2012 and compared to $4.7 million for the quarter ended June 30, 2011 and loss from continuing operations for the quarter ended June 30, 2012 was ($4.8) million as compared to ($1.4) million for the quarter ended March 31, 2012 and compared to ($1.6) million for the quarter ended June 30, 2011.

Second Quarter 2012 Financial Results Summary from Continuing Operations

  • Total revenue decreased to $1.9 million for the three months ended June 30, 2012 from $4.7 million for the three months ended June 30, 2011.
  • Strategic Services revenue decreased by 62% over second quarter 2011.
  • Intelligence and Insights revenue increased by 32% over second quarter 2011.
  • Total expenses increased to $7.3 million for the three months ended June 30, 2012 from $6.2 million for the three months ended June 30, 2011. The expenses for the three months ended June 30, 2012 included an impairment loss related to goodwill and intangibles of $4.8 million.
  • Loss from continuing operations for the three months ended June 30, 2012 was ($4.8) million, which included the following non-cash expenses: $4.8 million impairment loss, $259,000 in non-cash depreciation and amortization, and $91,000 in non-cash stock-based compensation expense related to vesting options, partially offset by a non-cash benefit of $516,000 from the provision for income tax. Loss from continuing operations for the three months ended June 30, 2011 was ($1.6) million, which included the following non-cash expenses: $310,000 in non-cash depreciation and amortization and $186,000 in non-cash stock-based compensation expense related to vesting options.

Discontinued Operations

During the quarter ended June 30, 2012, as part of the Company’s strategy to maximize cash flow, the Company decided to dispose of certain of its operating divisions that are included in its Intelligence and Insights segment. On June 4, 2012, the Company entered into a non-binding letter of intent with IPFlow International, LLC to sell its Pharmalicensing, Pharma Transfer, Global Licensing and Knowledge Express operating divisions and all related assets for $2,000,000. Under the letter of intent, a definitive agreement had to be reached before August 4, 2012. However, the Company is in continuing discussions with the buyer and believes that it is probable that a definitive agreement will still be reached. The agreement remains subject to customary conditions including negotiation of mutually agreeable terms, satisfactory completion of due diligence and the buyer securing financing. No assurances can be provided that a definitive agreement will be reached and that the sale will be completed.

1 of 4

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
SYM TRADE IT LAST %CHG

Markets

DOW 18,010.68 -115.44 -0.64%
S&P 500 2,107.39 -13.40 -0.63%
NASDAQ 5,070.0260 -27.95 -0.55%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs